Latest Operational Costs News

The Tennant Creek Copper Alliance, comprising CuFe, Emmerson Resources, and Tennant Minerals, has secured $600,000 in government grants matched by the companies to fund a feasibility study for a shared critical minerals processing facility in Tennant Creek.

The Tennant Creek Copper Alliance has won $600,000 in government grants, matched by the partners, to fund a feasibility study for a shared critical minerals processing facility. This initiative aims to unlock the economic potential of copper, gold, silver, and bismuth resources in the Northern Territory.

Aspermont Limited reported a $1.49 million net cash outflow in Q1 FY26 but maintains its forecast to become cash generative by Q3, supported by strong trading performance and strategic progress.

Great Divide Mining has completed its acquisition of the remaining Challenger Mines shares, gaining full ownership and setting a revised, sole-funded development plan targeting initial cashflow by the end of Q3 FY26.

Pursuit Minerals has delivered a compelling Pre-Feasibility Study for its Rio Grande Sur lithium project in Argentina, confirming strong economics and a maiden Ore Reserve. The company also secured a A$7 million capital raise to advance development.

Pivotal Metals has revealed ore sorting test results at its Horden Lake project that deliver up to a 2.1 times uplift in copper grade, promising substantial cost savings and flexible development options in Quebec’s Tier 1 mining jurisdiction.

Orthocell Ltd reports steady progress in commercialising its nerve repair product Remplir in the US, with sales growth, expanded distributor networks, and manufacturing upgrades underpinning its path to profitability.

Adheris Health has expanded its operating cost reduction program, aiming for more than 30% savings by FY27, while refocusing on high-growth pharmaceutical categories and enhancing its AI-powered patient engagement platform.

Small caps did the heavy lifting this week, led by two big discovery stories in resources. Funding raises and takeover moves kept attention on who can pay for the next step, not just promise it.

Big moves came from consumer fintech names as investors quickly re-priced growth, losses, and capital needs. A capital-raise week also split the market: some raisings steadied prices, others triggered fresh selling.

Speculative money piled into new discoveries and tight-supply metals, while a handful of small caps were sold hard on thin liquidity. The week’s biggest moves came from PGMs and tungsten on the way up, and micro-cap gas on the way down.

A handful of healthcare names did the heavy lifting this week, driven by FDA wins, guideline upgrades, and big shifts in sales and cashflow. The flip side: several clinical-stage stocks fell hard as investors stayed picky about near-term proof and funding.